test Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories,...
Chembio Diagnostics' analysts are forecasting revenues of US$54m in 2021, a substantial 56% improvement in sales compared to the last year. CEMI follows its bigger more profitable brother CODX in price action. Depending on the future development of the global pandemic, those stocks could grow rapidly. On 12/3/2020 Craig Hallum brokerage Upgraded the stock from...
Tomorrow Chembio Diagnostics CEMI will Report Second Quarter 2021 Financial Results. Things to consider: $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), for the purchase of HIV 1/2 STAT-PAK Assay for shipment to Ethiopia those are just some...
CEMI made a heck of a run on 7/21 so I figured we should do a quick and dirty Fib Retracement. Using the most recent low as the anchor and the high from JUST before CEMI gapped down last June, the candles line up with some interesting levels. It looks like the 786 fib line has consistently held as major support before breaking down below it this last time around....
All, I think CEMI is due for a huge run here oversold massively on almost all timeframes like daily/weekly. This has been building up and end of pattern now. I'd either scale in or get OTM options but further out.
All, This looks to be an inverse head and shoulders breakout and retest just slow and sloppy. Be careful, but this could definitely move. Always wait for conformation above highlighted area.
Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are...
Cup and handle with a range of $2+ (without catalyst) to its catalyst this thing could be a monster in disguise
Very interesting and sneakily bullish chart! PT 11$ and then $30 and eventually 300$ for the gap fill (probably 5 years from now).
$CEMI on a roll here, looking to fill the gap on the daily. Weekly chart looking awesome as well. Expecting to beat earnings in 8/6. Chembio is also trading in a corrective bullish trend and respecting trendline.
This one is too easy as well. This will fill the gap on short squeeze and chart technical easily.
CEMI testing the tripple bottom arround the $3.55 mark. Bullish pattern indicater , Needs to break past the 3 resistance points marked on the chart , 3.80 being the first. If the 3.55 fails we could drop down to the $3.30 support line. Anything under 3.70 looks like a good entry point to me. Looking at the fundamentals the company is undervalued and currently...